The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Burkitt Lymphoma: Detailed Diagnosis and Treatment

Aggressive MYC-translocation B-cell lymphoma requiring rapid intervention

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Burkitt Lymphoma: Detailed Diagnosis and Treatment?

Burkitt lymphoma harbors a translocation of the MYC oncogene with immunoglobulin heavy or light chain genes, most commonly t(8;14).

WHO recognizes endemic (equatorial Africa, EBV-associated), sporadic (worldwide) and immunodeficiency-associated (HIV, transplant) variants.

Pathology shows medium-sized blastic cells with starry sky pattern from interspersed macrophages clearing apoptotic debris.

Tumor doubling time is short and tumor lysis syndrome risk is high before and during treatment.

Diagnosis combines morphology, immunophenotype (CD20+, CD10+, BCL6+, BCL2-, Ki-67 near 100 percent) and molecular confirmation.

Symptoms

Rapidly growing painless lymphadenopathy or abdominal mass, with frequent ileocecal involvement in sporadic disease.
Jaw or facial mass especially in endemic Burkitt lymphoma in pediatric patients.
B symptoms with fever, drenching night sweats and significant weight loss.
Symptoms of bowel obstruction, intussusception or gastrointestinal bleeding from intra-abdominal disease.
Central nervous system involvement causes headache, cranial nerve deficits, paresthesias or focal weakness.

Risk Factors

Endemic disease is associated with chronic Epstein-Barr virus infection and malaria in equatorial Africa.
HIV infection significantly increases risk of sporadic and immunodeficiency variants.
Post-transplant immunosuppression is a recognized predisposing factor.
Hereditary immunodeficiencies and certain inflammatory conditions increase susceptibility.
Male sex and pediatric age groups have higher incidence in sporadic disease.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Rapidly enlarging mass, jaw swelling, severe abdominal pain or bowel obstruction warrants immediate evaluation.
  • Persistent unexplained fever, night sweats or weight loss requires hematology referral.
  • Neurologic deficits, severe headache or cranial nerve symptoms indicate possible central nervous system disease.
  • Patients beginning chemotherapy with rising potassium, phosphorus or creatinine need urgent intervention for tumor lysis syndrome.
  • Long-term follow-up is essential to detect relapse, secondary malignancies and treatment-related late effects.

Treatment Methods

01
Risk-adapted intensive multi-agent chemotherapy is the standard, with regimens such as CODOX-M/IVAC or DA-EPOCH-R.
02
Rituximab combined with chemotherapy improves outcomes in adults with all risk groups.
03
Mandatory central nervous system prophylaxis with intrathecal therapy (methotrexate, cytarabine) is included.
04
Aggressive prevention and management of tumor lysis syndrome with hydration, allopurinol and rasburicase is critical.
05
Allogeneic or autologous stem cell transplantation may be considered for relapsed disease, with novel agents and clinical trials providing additional options for refractory cases.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Burkitt Lymphoma

Hematoloji

Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma characterized by translocations involving the c-MYC oncogene (most commonly t(8;14)), with three clinical variants (endemic, sporadic, immunodeficiency-associated), exceptionally high proliferation rate, and excellent prognosis with intensive chemotherapy in pediatric and adult patients.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.